Literature DB >> 12697383

Intravenous toxicity of fructose-1,6-bisphosphate in rats.

Fernanda Bordignon Nunes1, Patrick Barcelos Gaspareto, Roberto Christ Vianna Santos, Márcio de Assis, Cássio Meyer Graziottin, Vanderlei Biolchi, José Carlos Farias Alves Filho, Adroaldo Lunardelli, Luís D Avila, Melissa Guerra Simões Pires, Paulo Harald Wächter, Jarbas Rodrigues De Oliveira.   

Abstract

Fructose-1,6-bisphosphate (FBP) is a bisphosphorilated sugar with a protective action against events that lead to cellular damage. The toxicity of the drug was assessed when administered intravenously in Wistar rats in doses of between 250 and 4000 mg/kg. Ionic calcium, total calcium, inorganic serum phosphate and the electrocardiographic profile of these animals were assessed. The lethal dose (LD(50)) was established by means of PROBIT processing. There was no reduction in the levels of total calcium, with the administration of increased doses of FBP, although there was a significant reduction in the levels of ionic calcium in those groups that received 250 mg/kg and over. The serum phosphate showed a significant statistical increase in those groups that received 750 mg/kg and over. The LD(50) obtained in 24 h was 1068 mg/kg. Though it was not possible to elucidate the toxic mechanism of FBP, the electrocardiogram (ECG) showed that all the rats died of cardiac arrest.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697383     DOI: 10.1016/s0378-4274(03)00075-4

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

1.  Fructose-1,6-bisphosphate reduces the mortality in Candida albicans bloodstream infection and prevents the septic-induced platelet decrease.

Authors:  Roberto Christ Vianna Santos; Rafael Noal Moresco; Miguel Angel Peña Rico; Antonio R García Susperregui; Jose Luis Rosa; Ramon Bartrons; Francesc Ventura; Débora Nunes Mário; Sydney Hartz Alves; Etiane Tatsch; Helena Kober; Ricardo Obalski de Mello; Patrícia Scherer; Henrique Bregolin Dias; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  Effect of fructose-1,6-bisphosphate on the nephrotoxicity induced by cisplatin in rats.

Authors:  Alan Arrieira Azambuja; Adroaldo Lunardelli; Fernanda Bordignon Nunes; Patrick Barcelos Gaspareto; Márcio Vinícius Fagundes Donadio; Carlos Eduardo Poli de Figueiredo; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2011-02       Impact factor: 4.092

3.  Fructose-1,6-bisphosphate protects against Zymosan-induced acute lung injury in mice.

Authors:  Roberto Christ Vianna Santos; Rafael Noal Moresco; Miguel Angel Peña Rico; Antonio R García Susperregui; Jose Luis Rosa; Ramon Bartrons; Francesc Ventura; Débora Nunes Mário; Sydney Hartz Alves; Etiane Tatsch; Helena Kober; Ricardo Obalski de Mello; Patrícia Scherer; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  Fructose-1,6-bisphosphate inhibits in vitro and ex vivo platelet aggregation induced by ADP and ameliorates coagulation alterations in experimental sepsis in rats.

Authors:  Luciana M de Oliveira; Melissa G Simões Pires; Alessandra B Magrisso; Terezinha P Munhoz; Rafael Roesler; Jarbas R de Oliveira
Journal:  J Thromb Thrombolysis       Date:  2009-08-25       Impact factor: 2.300

5.  Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats.

Authors:  Xiao-Yuan Lian; Firdous A Khan; Janet L Stringer
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

6.  Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway.

Authors:  Flávio P Veras; Raphael S Peres; André L L Saraiva; Larissa G Pinto; Paulo Louzada-Junior; Thiago M Cunha; Jonas A R Paschoal; Fernando Q Cunha; José C Alves-Filho
Journal:  Sci Rep       Date:  2015-10-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.